CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

The excerpt describes a tiered reward/pricing condition: the relevant price level must be met on the 3, 6, 9, or 12 month observation dates. It contrasts this with an earlier statement implying the price needed to be sustained continuously over the whole period. No company, macro, or market outcome is specified.

Analysis

The excerpt describes a tiered reward/pricing condition: the relevant price level must be met on the 3, 6, 9, or 12 month observation dates. It contrasts this with an earlier statement implying the price needed to be sustained continuously over the whole period. No company, macro, or market outcome is specified.